immunology

Pharma

Obesity meds, China drive $2T in projected 2032 drug sales: report

Together, drugs tackling obesity and inflammatory conditions are expected to push global pharmaceutical sales above $2 trillion in 2032, per Evaluate.

Fraiser Kansteiner Jun 23, 2026 9:00am

Biogen lays out $5.6B to acquire Apellis

Mar 31, 2026 10:32am

Galderma doubles Nemluvio peak sales outlook to $4B-plus

Mar 5, 2026 11:20am

Sanofi inks $1.5B deal for Sino Biopharm's novel asset

Mar 4, 2026 3:00am

AbbVie snaps up device plant amid broader $10B US investment

Jan 12, 2026 9:17am

cost cutting restructuring savings reduce spend

InflaRx charts layoffs, cost cuts to lift lead asset's prospects

Jan 8, 2026 11:03am